[1] Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020. 396(10251): 635-648.
[2] Arnold M, Abnet CC, Neale RE, et al. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology. 2020. 159(1): 335-349.e15.
[3] Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics. Cancer Commun (Lond). 2019. 39(1): 22.
[4] Cao M, Li H, Sun D, Chen W. Cancer burden of major cancers in China: A need for sustainable actions. Cancer Commun (Lond). 2020. 40(5): 205-210.
[5] Carlberg C, Muñoz A. An update on vitamin D signaling and cancer. Semin Cancer Biol. 2020 .
[6] Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev. 2016. 96(1): 365-408.
[7] Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019. 20(2): 69-84.
[8] Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014. 14(5): 342-57.
[9] Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010. 25(9): 603-5.
[10] Zeng X, Zhang Y, Kwong JS, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015. 8(1): 2-10.
[11] Kwak JH, Paik JK. Vitamin D Status and Gastric Cancer: A Cross-Sectional Study in Koreans. Nutrients. 2020. 12(7).
[12] Kevin A, Anandhi A, Lakshminarayanan S, Sureshkumar S, Kamalanathan S. Association between serum 25-hydroxy Vitamin D level and gastric adenocarcinoma-A cross sectional study. Przeglad GastroenterologicznyPrz. Gastroenterol.. 2021. 16(2): 155.
[13] Zeng Y, Chu Y, Sun J. Relationship Between Serum 25-(OH) D3, Ca2+ and Gastric Carcinoma. Cancer Research on Prevention and Treatment. 2015. (04): 369-372.
[14] Bao AY. Clinical Significance of Serum 25-Hydroxyvitamin D Level of Gastric Cancer Patients. Journal of Modern Laboratory Medicine. 2016. 0(2).
[15] Eom SY, Yim DH, Kim DH, et al. Dietary vitamin D intake and vitamin D related genetic polymorphisms are not associated with gastric cancer in a hospital-based case-control study in Korea. J Biomed Res. 2018. 32(4): 257-263.
[16] Durak Ş, Gheybi A, Demirkol Ş, et al. The effects of serum levels, and alterations in the genes of binding protein and receptor of vitamin D on gastric cancer. Molecular Biology ReportsMol. Biol. Rep.. 2019. 46(6): 6413.
[17] Hedayatizadeh-Omran A, Janbabaei G, Alizadeh-Navaei R, Amjadi O, Izadi JM, Omrani-Nava V. Association between pre-chemotherapy serum levels of Vitamin D and clinicopathologic findings in gastric cancer. Caspian Journal of Internal MedicineCaspian J. Int. Med.. 2020. 11(3): 290.
[18] Wang XL, Fan CG, Yang LI, Guo-Li LI. Correlations between serum 25(OH) vitamin D levels and the prognosis of advanced gastric cancer patients with neoadjuvant chemotherapy. Parenteral & Enteral Nutrition. 2019. 26(1).
[19] LI Qiang SUY, Wei-Guo R. Clinical significance of serum 1,25-(OH)2D3 level in elderly patients with gastric cancer. Chin J Mult Organ Dis Elderly. 2014. 13(5).
[20] Ren C, Qiu M-Z, Wang D-S, et al. Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer. J Transl Med. 2012 : 16.
[21] Ferrer-Mayorga G, Gómez-López G, Barbáchano A, et al. Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer. Gut. 2017. 66(8): 1449-1462.
[22] Liu C, Shaurova T, Shoemaker S, Petkovich M, Hershberger PA, Wu Y. Tumor-Targeted Nanoparticles Deliver a Vitamin D-Based Drug Payload for the Treatment of EGFR Tyrosine Kinase Inhibitor-Resistant Lung Cancer. Mol Pharm. 2018. 15(8): 3216-3226.
[23] Huang Z, Zhang Y, Li H, et al. Correction: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3. Cell Death Dis. 2020. 11(3): 190.
[24] Kotlarz A, Przybyszewska M, Swoboda P, et al. Imatinib inhibits the regrowth of human colon cancer cells after treatment with 5-FU and cooperates with vitamin D analogue PRI-2191 in the downregulation of expression of stemness-related genes in 5-FU refractory cells. J Steroid Biochem Mol Biol. 2019. 189: 48-62.
[25] Urashima M, Ohdaira H, Akutsu T, et al. Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers: The AMATERASU Randomized Clinical Trial. JAMAJAMA. 2019. 321(14): 1361.
[26] Yonaga H, Okada S, Akutsu T, Ohdaira H, Suzuki Y, Urashima M. Effect modification of vitamin D supplementation by histopathological characteristics on survival of patients with digestive tract cancer: Post hoc analysis of the AMATERASU randomized clinical trial. NutrientsNutrients. 2019. 11(10).
[27] Urashima M, Okuyama M, Akutsu T, Ohdaira H, Kaji M, Suzuki Y. Effect of vitamin D supplementation on survival of digestive tract cancer patients with low bioavailable 25-hydroxyvitamin d levels: A post hoc analysis of the AMATERASU randomized clinical trial. CancersCancers. 2020. 12(2).